Updated COVID-19 vaccines targeting JN.1-lineage omicron variants of the coronavirus are now available in the U.S. for the fall and winter seasons. Here we answer common questions about the latest ...

Last year, the TGA approved Pfizer's XBB.1.5 vaccine in October. It was made available in early December. What about Moderna and Novavax's new COVID-19 vaccines? Pfizer and Moderna COVID-19 ...

“However, all three of [them] have escaped [immunity] up to five- to tenfold, compared to the XBB variant contained ... that the other manufacturers, Moderna and Pfizer-BioNTech, use in their ...

Cost of sales dropped 77% thanks to well-managed costs and strategic pivots. Moderna reported earnings that exceeded expectations due to effective cost management but still has challenges related ...

The HKU scholar also said the XBB vaccine was effective against the ... jabs to mRNA boosters from makers such as BioNTech and Moderna was also an “extremely safe and very effective” option ...

1-lineage variants of omicron rather than the XBB.1.5 omicron variant. This is akin to a strain change for a seasonal ...

1-lineage variants of omicron rather than the XBB.1.5 omicron variant. This is akin to a strain change for a seasonal influenza vaccine. For the Pfizer/BioNTech and Moderna vaccines, this means ...